Prediction of the presence of insulin resistance using general health checkup data in Japanese employees with metabolic risk factors.
暂无分享,去创建一个
I. Shimomura | H. Kaneto | Iichiro Shimomura | Hideaki Kaneto | M. Takahara | N. Katakami | Naoto Katakami | Mitsuyoshi Takahara | Midori Noguchi | Midori Noguchi
[1] M. Matsuda,et al. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.
[2] Eiji Oda,et al. New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[3] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[4] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[5] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[6] M. Matsuda,et al. Reduced Time Points to Calculate the Composite Index , 2010, Diabetes Care.
[7] C. Yamada,et al. Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population , 2011, Journal of diabetes investigation.
[8] B. Howard,et al. Definition and Diagnostic Criteria for Metabolic Syndrome , 2011 .
[9] T. Funahashi,et al. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. , 2011, Journal of atherosclerosis and thrombosis.
[10] S. Kaneko,et al. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. , 2012, Endocrine journal.
[11] C. Yamada,et al. Association between insulin resistance and metabolic syndrome risk factors in Japanese , 2011, Journal of diabetes investigation.
[12] H. Mugishima,et al. Association of changes in body fatness and fatty acid composition of plasma phospholipids during early puberty in Japanese children. , 2012, Journal of atherosclerosis and thrombosis.
[13] K. Hayashi,et al. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. , 2012, Journal of atherosclerosis and thrombosis.
[14] R. Mitsui,et al. Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese , 2012, Journal of diabetes investigation.
[15] T. Ninomiya,et al. Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study. , 2012, Journal of atherosclerosis and thrombosis.
[16] 上谷 英里. Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance : the J-SHIPP study , 2012 .
[17] M. Katakura,et al. Hyperbolic correlation between insulin sensitivity and insulin secretion fades away in lean subjects with superb glucose regulation. , 2012, Endocrine journal.
[18] M. Nakazato,et al. Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia. , 2012, Journal of atherosclerosis and thrombosis.
[19] Hiroshi Ito,et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values , 2012, Journal of diabetes investigation.
[20] M. Yamagishi,et al. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. , 2012, Endocrine journal.
[21] Bo Hu,et al. Decreased beta cell function and insulin sensitivity contributed to coronary artery disease in patients with normal glucose tolerance. , 2012, Journal of atherosclerosis and thrombosis.
[22] I. Shimomura,et al. Statistical reassessment of the association between waist circumference and clustering metabolic abnormalities in Japanese population. , 2012, Journal of atherosclerosis and thrombosis.
[23] Y. Altuntas,et al. Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients. , 2012, Endocrine journal.
[24] T. Yoo,et al. Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients. , 2012, Endocrine journal.
[25] C. Yamada,et al. Optimal cut‐off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non‐diabetic Japanese subjects , 2012, Journal of diabetes investigation.
[26] S. Yamashita,et al. Management of type IIb dyslipidemia. , 2012, Journal of atherosclerosis and thrombosis.
[27] Y. Ohno,et al. Impact of cigarette smoking on impaired insulin secretion and insulin resistance in Japanese men: The Saku Study , 2012, Journal of diabetes investigation.
[28] Yoshinobu Morikawa,et al. Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals - possible involvement of the insulin resistance -. , 2013, Endocrine journal.
[29] T. Funahashi,et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. , 2013, Endocrine journal.
[30] I. Shimomura,et al. Distribution of the Matsuda Index in Japanese healthy subjects , 2013, Journal of Diabetes Investigation.
[31] 宮内 省蔵. Interleukin-18 induces insulin resistance in the hyperthyroid state , 2013 .
[32] Effects of a fixed combination of losartan with hydrochlorothiazide on glucose tolerance in hypertensive patients uncontrolled with angiotensin ii receptor blockers alone. , 2013, Journal of atherosclerosis and thrombosis.
[33] I. Shimomura,et al. Insulin resistance can be easily estimated by body mass index and waist circumference in a general Japanese population. , 2013, Journal of atherosclerosis and thrombosis.
[34] R. Kawamori,et al. Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia , 2013, Journal of diabetes investigation.
[35] Yoshiya Tanaka,et al. Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension. , 2013, Endocrine journal.